Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Bristol Myers Squibb (NYSE: BMY) today published its 2023 Environmental, Social, and Governance (ESG) Report detailing the company’s meaningful progress, evolved strategy, and aspirational goals toward its ESG efforts.
- Bristol Myers Squibb (NYSE: BMY) today published its 2023 Environmental, Social, and Governance (ESG) Report detailing the company’s meaningful progress, evolved strategy, and aspirational goals toward its ESG efforts.
- The company’s ESG strategy is embedded in its mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
- View the full release here: https://www.businesswire.com/news/home/20240402638203/en/
“For more than 130 years, BMS has enabled positive change for our patients around the world. - Incorporated new ESG metrics into the executive compensation program, measuring achievement against environmental and social goals and better aligning executive bonuses with company strategy.